Can Early B-Type Natriuretic Peptide Assays Predict Symptomatic Patent Ductus Arteriosus in Extremely Low Birth Weight Infants?

Publisher： Karger

E-ISSN： 1661-7819|103|2|118-122

ISSN： 1661-7800

Source： Neonatology, Vol.103, Iss.2, 2012-11, pp. : 118-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants

By Yang Chuan-Zhong  

World Journal of Pediatrics, Vol. 4, Iss. 2, 2008-05 ,pp. : 91-96

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous Paracetamol Treatment in the Management of Patent Ductus Arteriosus in Extremely Low Birth Weight Infants

By  

Neonatology, Vol. 103, Iss. 3, 2012-12 ,pp. : 166-169

Karger

Access to resources Recommend Favorite

Near-Infrared Spectroscopy as a Screening Tool for Patent Ductus Arteriosus in Extremely Low Birth Weight Infants

By  

Neonatology, Vol. 91, Iss. 2, 2006-11 ,pp. : 134-139

Karger

Access to resources Recommend Favorite

Adequate Timely Treatment of Patent Ductus Arteriosus in Extremely Low Birth Weight Infants: An Ongoing Challenge

By  

Neonatology, Vol. 107, Iss. 4, 2015-02 ,pp. : 256-256

Karger

Access to resources Recommend Favorite

Urinary NT-proBNP, NGAL, and H-FABP May Predict Hemodynamic Relevance of Patent Ductus Arteriosus in Very Low Birth Weight Infants

By  

Neonatology, Vol. 101, Iss. 4, 2012-01 ,pp. : 260-266

Karger

Access to resources Recommend Favorite